American journal of ophthalmology۲۰۲۶مطالعه مشاهده اینمایه شده در PubMed
Isabella H Yazji, Nadia J Abbass, David C Kaelber, Katherine E Talcott, Rishi P Singh
چکیده
PCSK9 inhibitors (PCSK9i) are a newer class of lipid-lowering drug that may be effective at lowering risk for retinal artery occlusion (RAO) and retinal vein occlusion (RVO). This study aims to investigate the relationship between PCSK9i use and retinal vascular occlusion among patients with…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1016/j.ajo.2026.06.038